Max Fedor is the Executive Director of Pittsburgh CREATES at the University of Pittsburgh, a transdisciplinary collaborative that supports training, education, and sponsored research for
advanced surgical technologies.

Before joining CREATES, Max was the Director of the Coulter Translational Research Partners II Program, also at the University of Pittsburgh, providing qualified faculty-directed biomedical
research teams with funding, support and mentorship to accelerate the translation of their innovative technologies to commercialization. In addition, he brings 30 years of industry experience in technology development, business development, capital raising, and general management for companies ranging from start-ups to Fortune 500 entities. Most recently, he was President and CEO of BIOSAFE, Inc., an antimicrobial coatings company that was acquired by a leader in specialty chemicals. Prior to that, he was an Executive-in- Residence at the Pittsburgh Life Sciences Greenhouse, helping early stage portfolio companies to achieve initial capitalization and commercial launch. Max has also held senior leadership positions in other life science technology companies, including Vice President of Business Development for Bioimagene, Inc., a software solutions provider for diagnostic image analytics, Vice President of Development and Operations for Tissue Informatics (acquired by Bioimagene), Senior Program Manager for in-vitro diagnostic platforms at Alstom Automation Systems, Inc. (a prime contractor for Bayer Diagnostics), President and Co-Founder of MedSelect Systems, and President and Co-Founder of Ergonics Corp.

He holds an MBA from the Tepper School of Business at Carnegie Mellon University and a bachelor’s degree in Engineering and Applied Sciences from Harvard College.